ivabradine has been researched along with Cardiomyopathies in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (13.64) | 29.6817 |
2010's | 12 (54.55) | 24.3611 |
2020's | 7 (31.82) | 2.80 |
Authors | Studies |
---|---|
Arotsker, N; Besser, L; Bichovsky, Y; Fraenkel, M; Frenkel, A; Joshua, BZ; Klein, M; Zahger, D | 1 |
Bradley, JL; Gao, S; Hu, Z; Ornato, JP; Peberdy, MA; Tang, W; Xu, B; Yang, J | 1 |
Gao, W; Guo, Y; Huang, M; Li, F; Liu, T; Xu, X | 1 |
AlDhahri, F; Kharal, M; Mahmood, N; Rajendram, R | 1 |
Guo, Y; Huang, MR; Li, F; Liu, TL; Xu, XY | 1 |
Fang, H; Shen, Z; Wang, L; Zhang, Y; Zhou, Z | 1 |
Cilsal, E; Ergul, Y; Guzeltas, A; Ozgur, S; Ozturk, E; Ozyurt, A | 1 |
Kavtaradze, N; Saganelidze, K | 1 |
Ergul, Y; Ozturk, E | 1 |
Mert, GÖ; Mert, KU; Şener, E | 1 |
Doškář, P; Dujka, L; Koščová, K; Kučerová, A; Lekešová, V; Málek, F; Neužil, P; Volf, P | 1 |
Adorisio, R; Amodeo, A; Baban, A; Bertini, E; Calvieri, C; Cantarutti, N; Catteruccia, M; D'Amico, A; Drago, F; Filippelli, S; Perri, G | 1 |
Chen, L; Hua, T; Yang, M; Yang, Z; Zou, Y | 1 |
Rozec, B | 1 |
Al-Kindi, SG; Oliveira, GH; Orasanu, G | 1 |
van de Borne, P | 1 |
Beck, L; Cayla, G; Messner-Pellenc, P; Rubini, M; Winum, PF | 1 |
Becker, M; Koch, KC; Lepper, W; Westenfeld, R; Zwicker, C | 1 |
Bohora, S; Lokhandwala, Y; Parekh, P; Vasavda, A | 1 |
Calabrò, R; D'Alto, M; Grimaldi, N; Romeo, E; Russo, MG; Santarpia, G; Sarubbi, B; Scognamiglio, G | 1 |
Gray, B; Kuchar, D; Macdonald, P | 1 |
Cargnoni, A; Ceconi, C; Ferrari, R | 1 |
4 review(s) available for ivabradine and Cardiomyopathies
Article | Year |
---|---|
[Heart rate control in patients with sepsis and septic cardiomyopathy: the role of Ivabradine].
Topics: Benzazepines; Cardiomyopathies; Heart Rate; Humans; Ivabradine; Sepsis | 2020 |
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failure; Heart Valve Diseases; Humans; Ivabradine; Myocardial Infarction; Myocardial Ischemia; Patient Selection; Stereoisomerism; Vasodilator Agents | 2008 |
Anti-ischaemic effect of ivabradine.
Topics: Animals; Benzazepines; Cardiomyopathies; Depression, Chemical; Heart Rate; Humans; Ion Channels; Ivabradine | 2006 |
18 other study(ies) available for ivabradine and Cardiomyopathies
Article | Year |
---|---|
Ivabradine for Uncontrolled Sinus Tachycardia in Thyrotoxic Cardiomyopathy - Case Report.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathies; Female; Heart Failure; Humans; Ivabradine; Tachycardia, Sinus; Thyrotoxicosis | 2023 |
IVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT MODEL OF CARDIOPULMONARY RESUSCITATION.
Topics: Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Epinephrine; Heart Rate; Ivabradine; Rats; Rats, Sprague-Dawley; Troponin I | 2022 |
Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Female; Humans; Ivabradine; Stroke Volume; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Cardiovascular Agents; Diagnosis, Differential; Female; Humans; Ivabradine; Metoprolol; Muscular Dystrophies, Limb-Girdle; Tachycardia, Sinus; Young Adult | 2020 |
[Successful treatment of atrial tachycardia induced cardiomyopathy by ivabradine].
Topics: Cardiomyopathies; Heart Rate; Humans; Ivabradine; Tachycardia, Supraventricular; Treatment Outcome | 2021 |
Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: Case studies.
Topics: Cardiomyopathies; Cardiovascular Agents; Electrocardiography; Female; Humans; Infant; Ivabradine; Male; Tachycardia, Ectopic Junctional | 2018 |
Ivabradine use as an antiarrhythmic therapy in congenital junctional ectopic tachycardias.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Humans; Ivabradine; Tachycardia, Ectopic Junctional; Vascular Diseases | 2018 |
Beneficial effects of ivabradine in atrial or ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; Ivabradine; Tachycardia, Ectopic Junctional | 2018 |
Heart rate reduction after ivabradine might be associated with reverse electrical remodeling in patients with cardiomyopathy and left bundle branch block.
Topics: Adult; Aged; Atrial Remodeling; Bundle-Branch Block; Cardiomyopathies; Electrocardiography; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2018 |
Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy.
Topics: Adolescent; Adult; Cardiomyopathies; Cardiovascular Agents; Cohort Studies; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Magnetic Resonance Imaging, Cine; Male; Muscular Dystrophy, Duchenne; Pilot Projects; Prospective Studies; Young Adult | 2019 |
Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest.
Topics: Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Cardiovascular Agents; Disease Models, Animal; Heart Arrest; Ivabradine; Male; Stroke Volume; Swine; Ventricular Function, Left | 2020 |
How to slow down septic hearts?
Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiomyopathies; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Lipopolysaccharides; Myocardium; Sepsis | 2014 |
Ivabradine in Management of Heart Failure: a Critical Appraisal.
Topics: Arrhythmias, Cardiac; Benzazepines; Cardiomyopathies; Cardiovascular Agents; Clinical Studies as Topic; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Ultrasonography | 2016 |
A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine.
Topics: Aged; Benzazepines; Cardiomyopathies; Female; Humans; Ivabradine; Tachycardia, Sinus; Treatment Outcome | 2009 |
Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.
Topics: Adult; Benzazepines; Cardiomyopathies; Catheterization, Swan-Ganz; Diagnosis, Differential; Female; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Syncope; Tachycardia; Treatment Outcome | 2010 |
Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine.
Topics: Adolescent; Anti-Arrhythmia Agents; Benzazepines; Cardiomyopathies; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Ivabradine; Stroke Volume; Tachycardia, Supraventricular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine.
Topics: Adolescent; Benzazepines; Cardiomyopathies; Cyclic Nucleotide-Gated Cation Channels; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography, Ambulatory; Follow-Up Studies; Humans; Ivabradine; Male; Tachycardia, Sinus | 2011 |
Reversal of cardiomyopathy with ivabradine.
Topics: Benzazepines; Cardiomyopathies; Female; Humans; Ivabradine; Young Adult | 2011 |